Ambenonium chloride
From Wikipedia, the free encyclopedia
 |
|
|
Ambenonium chloride
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | N07 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C28H42Cl2N4O2+2 |
| Mol. mass | 537.564 g/mol |
| Pharmacokinetic data | |
| Bioavailability | Low |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Ambenonium (as ambenonium dichloride, trade name Mytelase) is a cholinesterase inhibitor used in the management of myasthenia gravis.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
